Free Trial

Tounjian Advisory Partners LLC Takes $9.43 Million Position in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Tounjian Advisory Partners LLC acquired a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 17,998 shares of the healthcare conglomerate's stock, valued at approximately $9,426,000. UnitedHealth Group comprises approximately 1.7% of Tounjian Advisory Partners LLC's portfolio, making the stock its 8th largest position.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. NewSquare Capital LLC acquired a new stake in shares of UnitedHealth Group during the fourth quarter valued at $25,000. Marshall & Sterling Wealth Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the fourth quarter worth about $26,000. Hurley Capital LLC purchased a new position in shares of UnitedHealth Group during the fourth quarter valued at approximately $28,000. Aster Capital Management DIFC Ltd purchased a new stake in UnitedHealth Group in the 4th quarter worth approximately $30,000. Finally, Promus Capital LLC acquired a new position in UnitedHealth Group in the 4th quarter valued at $32,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the company. Erste Group Bank downgraded UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Piper Sandler dropped their price objective on shares of UnitedHealth Group from $552.00 to $353.00 and set an "overweight" rating for the company in a research note on Tuesday, June 3rd. Raymond James downgraded shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a report on Wednesday, May 14th. Barclays cut their price target on shares of UnitedHealth Group to $350.00 and set an "overweight" rating on the stock in a research note on Monday, June 2nd. Finally, Robert W. Baird downgraded UnitedHealth Group from an "outperform" rating to a "neutral" rating and set a $312.00 price target for the company. in a research report on Wednesday. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and sixteen have given a buy rating to the stock. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $426.52.

Read Our Latest Analysis on UNH

Insiders Place Their Bets

In other news, CEO Stephen J. Hemsley purchased 86,700 shares of the company's stock in a transaction on Friday, May 16th. The shares were bought at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the purchase, the chief executive officer now owns 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy Patrick Flynn bought 1,533 shares of the stock in a transaction that occurred on Wednesday, May 14th. The stock was acquired at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the completion of the transaction, the director now owns 6,033 shares in the company, valued at $1,935,386.40. This trade represents a 34.07% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last three months, insiders have acquired 109,408 shares of company stock valued at $31,607,768. Company insiders own 0.28% of the company's stock.

UnitedHealth Group Stock Up 1.4%

Shares of UnitedHealth Group stock traded up $4.24 during trading hours on Wednesday, hitting $308.03. 11,210,248 shares of the company's stock traded hands, compared to its average volume of 7,079,714. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a twelve month low of $248.88 and a twelve month high of $630.73. The stock has a 50 day simple moving average of $399.88 and a 200-day simple moving average of $479.36. The company has a market cap of $279.43 billion, a PE ratio of 19.87, a PEG ratio of 1.37 and a beta of 0.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). The company had revenue of $109.58 billion for the quarter, compared to the consensus estimate of $111.56 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. During the same quarter last year, the company earned $6.91 earnings per share. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be given a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. The ex-dividend date of this dividend is Monday, June 16th. This represents a $8.84 annualized dividend and a dividend yield of 2.87%. UnitedHealth Group's dividend payout ratio (DPR) is presently 37.02%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Should You Invest $1,000 in UnitedHealth Group Right Now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Analysts Are Watching These 4 Penny Stocks—You Should Too
Congress Is Pouring Millions Into These 6 Surprising Stocks
3 Dirt-Cheap Stocks in a Market That’s Getting Expensive

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines